Otsuka, Lundbeck Seek Alzheimer's Agitation Claim For Antipsychotic

 
• By Lucie Ellis-Taitt
  
Neurology
Otsuka, Lundbeck target third indication for Rexulti in Alzheimer's disease
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D